Notice - Prescription Drug List (PDL): Esomeprazole
Description
The purpose of this Notice of Intent to Amend is to notify that, as a result of consultation, Health Canada will switch certain uses of Esomeprazole to nonprescription status for human use by modifying the Human Prescription Drug List (PDL).
Resources
| Name |
Format |
Description |
Link |
| Notice - Prescription Drug List (PDL): Esomeprazole |
HTML |
|
https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notice-esomeprazole-1.html |
| Notice - Prescription Drug List (PDL): Esomeprazole |
HTML |
|
https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/medicaments/liste-drogues-ordonnance/notice-esomeprazole.html |